Skip to main content English


Alexandra Kautzky-Willer
Univ.-Prof. Dr. Alexandra Kautzky-WillerManagement Team of the Department of Medicine III. Head of the Division of Endocrinology and Metabolism, the Gender Medicine Unit, and the University Course Gender Medicine.

Department of Medicine III (Division of Endocrinology and Metabolism)
Position: Professor

ORCID: 0000-0002-3520-4105
T +43 1 40400 22280

Further Information


-gender differences; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes, Gestational; Endocrinology; Gender Identity; Inflammation; Obesity; Sex Characteristics; Transgendered Persons

Research interests

  • Endocrinology
  • Gestational diabetes and fetal programming
  • Gender aspects of obesity
  • Gender aspects of metabolic syndrome
  • Gender aspects of type 2 diabetes
  • Gender aspects of type 1 diabetes/autoimmunity
  • Gender aspects of insulin resistance and beta cell function: Changes in pathogenesis of and interaction with different disease processes
  • Gender aspects of inflammation, adipokines, endothelial dysfunction

Techniques, methods & infrastructure

- Functional tests, insulin sensitivity, insulin secretion, incretins;
- Glucose monitoring
- Minimal modeling
- Spectroscopy


  • GOING-FWD Gender Outcomes INternational Group: to Further Well-being Development (2019)
    Source of Funding: FWF (Austrian Science Fund), GENDER-NET Plus ERA-NET Cofund
    Principal Investigator
  • Optimal gender-specific treatment paths on healthcare multiplex networks (2017)
    Source of Funding: WWTF (Vienna Science and Technology Fund), Mathematics and…
    Principal Investigator
  • Epigenetik-basierte Typ-2-Diabetes Diagnostik aus Speichel und Blut (2015)
    Source of Funding: FFG (Austrian Research Promotion Agency), FEMtech
    Principal Investigator
  • DIABgender: Gender-specific Diabetes Self-management (2014)
    Source of Funding: FFG (Austrian Research Promotion Agency), FEMtech FTI
    Principal Investigator
  • DALI: Vitamin D and lifestyle intervention for gestational diabetes mellitus (GDM) prevention (2010)
    Source of Funding: EU, FP7
    Principal Investigator

Selected publications

  1. Tomic, D. et al. (2022) ‘Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study’, The Lancet Diabetes & Endocrinology, 10(11), pp. 795–803. Available at:
  2. Paolino, M. et al. (2020) ‘RANK links thymic regulatory T cells to fetal loss and gestational diabetes in pregnancy’, Nature, 589(7842), pp. 442–447. Available at:
  3. Leutner, M. et al. (2019) ‘Diagnosis of osteoporosis in statin-treated patients is dose-dependent’, Annals of the Rheumatic Diseases, 78(12), pp. 1706–1711. Available at:
  4. Harreiter, J. et al. (2019) ‘Nutritional Lifestyle Intervention in Obese Pregnant Women, Including Lower Carbohydrate Intake, Is Associated With Increased Maternal Free Fatty Acids, 3-β-Hydroxybutyrate, and Fasting Glucose Concentrations: A Secondary Factorial Analysis of the European Multicenter, Randomized Controlled DALI Lifestyle Intervention Trial’, Diabetes Care, 42(8), pp. 1380–1389. Available at:
  5. Kautzky-Willer, A., Harreiter, J. and Pacini, G. (2016) ‘Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus’, Endocrine Reviews, 37(3), pp. 278–316. Available at: